Since 1994, Pappas Ventures has been nurturing promising life sciences ideas and delivering superior results to investors and entrepreneurs alike.
Portfolio Highlights
Pappas Ventures News
In the Spotlight
-
Arthur M. Pappas, Managing Partner
Art recently addressed the current FDA approval process in an article that appeared in the Venture Capital Journal entitled, “A Path Forward for the FDA.” In addition, Art was named one of the "Triangle's Most Influential Business Leaders" by Triangle Business Journal.
-
Chimerix
The Durham based antiviral drug development company successfully raised more than $100M in an initial public offering. The company trades on the Nasdaq under the ticker symbol CMRX.